Snowden Capital Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.57M Sell
36,740
-5,946
-14% -$416K 0.08% 256
2025
Q1
$3.14M Sell
42,686
-742
-2% -$54.5K 0.1% 217
2024
Q4
$2.85M Sell
43,428
-1,377
-3% -$90.2K 0.09% 225
2024
Q3
$3.49M Buy
44,805
+485
+1% +$37.8K 0.1% 220
2024
Q2
$3.46M Buy
44,320
+8,204
+23% +$640K 0.1% 227
2024
Q1
$2.45M Sell
36,116
-759
-2% -$51.4K 0.08% 287
2023
Q4
$2.48M Buy
36,875
+2,734
+8% +$184K 0.09% 246
2023
Q3
$2.31M Sell
34,141
-1,649
-5% -$112K 0.1% 252
2023
Q2
$2.56M Sell
35,790
-2,210
-6% -$158K 0.09% 250
2023
Q1
$2.64M Buy
38,000
+3,259
+9% +$226K 0.1% 243
2022
Q4
$2.36M Buy
34,741
+1,976
+6% +$134K 0.1% 252
2022
Q3
$1.8M Buy
32,765
+18,812
+135% +$1.03M 0.08% 283
2022
Q2
$921K Buy
13,953
+619
+5% +$40.9K 0.04% 441
2022
Q1
$884K Buy
13,334
+8,029
+151% +$532K 0.04% 474
2021
Q4
$309K Sell
5,305
-4,888
-48% -$285K 0.02% 563
2021
Q3
$612K Buy
10,193
+69
+0.7% +$4.14K 0.03% 479
2021
Q2
$606K Buy
10,124
+1,936
+24% +$116K 0.03% 486
2021
Q1
$407K Buy
8,188
+1,074
+15% +$53.4K 0.02% 541
2020
Q4
$356K Buy
7,114
+907
+15% +$45.3K 0.02% 499
2020
Q3
$340K Sell
6,207
-2,236
-26% -$123K 0.03% 444
2020
Q2
$447K Buy
8,443
+128
+2% +$6.77K 0.04% 395
2020
Q1
$371K Buy
8,315
+1,366
+20% +$61K 0.04% 396
2019
Q4
$346K Sell
6,949
-377
-5% -$18.8K 0.03% 456
2019
Q3
$327K Sell
7,326
-127
-2% -$5.66K 0.03% 410
2019
Q2
$308K Buy
7,453
+91
+1% +$3.76K 0.03% 407
2019
Q1
$298K Sell
7,362
-1,160
-14% -$46.9K 0.03% 404
2018
Q4
$324K Buy
8,522
+88
+1% +$3.34K 0.04% 368
2018
Q3
$334K Buy
8,434
+2,268
+37% +$89.8K 0.04% 378
2018
Q2
$216K Sell
6,166
-236
-4% -$8.29K 0.03% 411
2018
Q1
$224K Sell
6,402
-1,966
-23% -$68.8K 0.03% 353
2017
Q4
$290K Sell
8,368
-7,682
-48% -$267K 0.04% 335
2017
Q3
$544K Sell
16,050
-1,887
-11% -$63.9K 0.09% 252
2017
Q2
$611K Sell
17,937
-199
-1% -$6.78K 0.11% 215
2017
Q1
$565K Sell
18,136
-1,203
-6% -$37.5K 0.12% 211
2016
Q4
$528K Sell
19,339
-933
-5% -$25.5K 0.13% 189
2016
Q3
$666K Buy
20,272
+9,417
+87% +$309K 0.18% 164
2016
Q2
$328K Buy
+10,855
New +$328K 0.1% 216